Insulin resistance, a hallmark of prediabetes, contributes to chronic low-grade inflammation and endothelial dysfunction, which can in turn influence levels of circulating biomarkers such as IL-6, D-dimer, and S100B. This evidence concerns the gene S100B and Insulin resistance.